WebDisclosure WebDisclosure
Basculer en Français
9686 Companies
192888 Keywords
124214 Articles
102721 Press releases
Headlines Articles Press releases Generate:Biomedicines Remove
  1. Home
  2. Companies
  3. Generate:Biomedicines
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 12:10, 1 month 16 days ago

    Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

    Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
  • BRIEF

    published on 12/01/2025 at 12:10, 1 month 16 days ago

    Generate:Biomedicines lance des essais de phase 3 pour l'anticorps contre l'asthme GB-0895

    Essais De Phase 3 GB-0895 Générer : Biomédicaments Traitement De L'asthme Anticorps Conçu Par IA
  • PRESS RELEASE

    published on 12/01/2025 at 12:05, 1 month 16 days ago

    Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

    Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies
    AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma
    Logo of Generate:Biomedicines
Accesswire
  • Published on 01/17/2026 at 02:20, 12 hours 14 minutes ago

    Core Critical Metals Announces a 1 for 2 Stock Split

  • Published on 01/17/2026 at 01:00, 13 hours 34 minutes ago

    Wildpack Announces Leadership Transition

  • Published on 01/16/2026 at 23:19, 15 hours 15 minutes ago

    Silver North Announces Further Upsize of Brokered LIFE Private Placement for Gross Proceeds of up to C$10.6 Million

  • Published on 01/16/2026 at 23:00, 15 hours 34 minutes ago

    Silver Spruce Resources Inc. Announces Grant of Options

  • Published on 01/16/2026 at 22:55, 15 hours 39 minutes ago

    Silver Spruce Resources Inc. Announces Closing of $976,000 Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 01/17/2026 at 13:59, 34 minutes ago

    Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio

  • Published on 01/17/2026 at 13:56, 37 minutes ago

    Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program

  • Published on 01/16/2026 at 19:07, 19 hours 27 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 01/16/2026 at 18:36, 19 hours 58 minutes ago

    CPI PROPERTY GROUP – Completion of the Share Buy-back Offer

  • Published on 01/16/2026 at 18:12, 20 hours 22 minutes ago

    Westwing Group SE Trading Update: Westwing delivered a strong 9% GMV growth in Q4 2025 and significantly increased full-year 2025 guidance on adjusted EBITDA

View all EQS
Les Echos
  • Published on 01/16/2026 at 18:39, 19 hours 55 minutes ago

    Nombre total d'actions et droits de vote - décembre 2025

  • Published on 01/16/2026 at 18:39, 19 hours 55 minutes ago

    Number of shares and voting rights - December 2025 (In French only)

  • Published on 01/16/2026 at 17:45, 20 hours 49 minutes ago

    Half yearly report on the liquidity contract

  • Published on 01/16/2026 at 17:45, 20 hours 49 minutes ago

    Bilan semestriel du contrat de liquidité

  • Published on 01/16/2026 at 08:53, 1 day 5 hours ago

    www.entech-se.com COMMUNIQUÉ DE PRESSE Entech remporte un contrat pour la construction de 400 MWh de stockage d’énergie (BESS) en partenariat avec Eiffage Énergie Systèmes

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy